Category: Impella


Dr. Seth Bilazarian on the recent Circulation paper by Dr. Schrage/Dr. Ibrahim

Dr. Seth Bilazarian discusses a recent paper published in Circulation by Drs. Benedikt Schrage, Karim Ibrahim, et. al. on a retrospective matched-pair analysis comparing patients in cardiogenic shock treated with balloon pump and Impella. Dr. Bilazarian highlights several limitations of the analysis, which used a matched-pair analysis to “harmonize baseline characteristics” of Impella-treated patients with … Continue reading “Dr. Seth Bilazarian on the recent Circulation paper by Dr. Schrage/Dr. Ibrahim”

Analysis of Outcomes for 15,259 U.S. Patients with AMICS Supported with the Impella Device

Dr. William O’Neill outlines his recent publication of 15,529 AMI cardiogenic shock patients from the Impella Quality (IQ) database. The clinical publication highlights best practice protocols based on real-world evidence that is showing improved outcomes in cardiogenic shock. This clinical evidence is derived from Abiomed’s observational , commercial IQ database. In patients with AMICS receiving … Continue reading “Analysis of Outcomes for 15,259 U.S. Patients with AMICS Supported with the Impella Device”

Use of Impella® Device to Assess Left Ventricular Function: A Proof-of-Concept Study

Left ventricular end-diastolic pressure (LVEDP) refers to the pressure in the LV at the end of diastolic filling and immediately before ventricular contraction.1 It is a useful measure to assess cardiac function and is typically inferred from pulmonary capillary wedge pressure (PCWP). However, PCWP is prone to significant errors and some studies report discordance of … Continue reading “Use of Impella® Device to Assess Left Ventricular Function: A Proof-of-Concept Study”

Hemodynamic Benefits of Impella RP® Heart Pump for Right Heart Failure

Dr. William O’Neill and Dr. Mark Anderson, co-principle investigators of the RECOVER-RIGHT clinical trial, and Dr. Seth Bilazarian discuss the hemodynamic benefits of using the Impella RP® heart pump for right heart failure. The Impella RP® is the first and only percutaneous heart pump approved by the FDA as safe and effective for acute right … Continue reading “Hemodynamic Benefits of Impella RP® Heart Pump for Right Heart Failure”

Dr. Mark Goodwin Explains the Use of Impella RP® in Right Ventricular Stenosis

In this physician Q&A session, Dr. Mark Goodwin of Edward Hospital explains the clinical decision to use the Impella RP® in patients with right ventricular stenosis. Specifically, Dr. Goodwin explains the reasoning behind using the Impella RP instead of directly approaching the ventricular branches. Related Content: Dr. Bill O’Neill Discusses Recovery Time from RV and … Continue reading “Dr. Mark Goodwin Explains the Use of Impella RP® in Right Ventricular Stenosis”

Dr. Bill O’Neill Discusses Recovery Time from RV and LV Shock with Impella RP® Support

In this physician Q&A session, Dr. Bill O’Neill discusses recovery considerations as well as time to recovery following Impella RP® support for right ventricular (RV) and left ventricular shock. In this video, Dr. O’Neill also describes the rapid recovery (<24 hours) of patients with acute myocardial infarction receiving the Impella RP®. In addition, Dr. O’Neill … Continue reading “Dr. Bill O’Neill Discusses Recovery Time from RV and LV Shock with Impella RP® Support”

Impella RP® Weaning Recommendations from Dr. Tim Larkin

Dr. Tim Larkin of Edward Hospital describes his weaning protocol for the Impella RP® during this physician Q&A session. In this session, Dr. Larkin explains the utility of the pulmonary artery pulsatility index for gauging appropriate weaning time for the Impella RP. Dr. Larkin also recommends monitoring serum lactate for assessing tissue perfusion prior to … Continue reading “Impella RP® Weaning Recommendations from Dr. Tim Larkin”

Dr. Thorsten Siess, Abiomed’s CTO and Inventor of Impella® Shares his Insights on the Impella® Platform of Devices

Dr. Thorsten Siess, Abiomed’s Chief Technology Officer and inventor of Impella® discusses how the world’s smallest heart pump transformed from a product to a platform. Listen in to learn how the Abiomed team is developing new features to satisfy the clinician community’s needs. What new features are being developed by Dr. Siess now? Press play … Continue reading “Dr. Thorsten Siess, Abiomed’s CTO and Inventor of Impella® Shares his Insights on the Impella® Platform of Devices”

IMPRESS in Severe Shock Trial: Looking Closer at the Data

For patients with cardiogenic shock (CS), intra-aortic balloon pump (IABP) had been an important tool for maintaining patients and improving survival after percutaneous coronary intervention (PCI). Randomized controlled trials, however, have found very little evidence to support the notion that IABP is helpful for reducing mortality or improving hemodynamics for patients with CS.1,2 The Impella® … Continue reading “IMPRESS in Severe Shock Trial: Looking Closer at the Data”